• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究考虑油的粘度和表面张力时,药物浓度对中链甘油三酯体外脂肪分解动力学的影响。

Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension.

机构信息

University of Basel, Division of Pharmaceutical Technology, Basel, Switzerland.

出版信息

Eur J Pharm Sci. 2011 Oct 9;44(3):351-8. doi: 10.1016/j.ejps.2011.08.009. Epub 2011 Aug 25.

DOI:10.1016/j.ejps.2011.08.009
PMID:21884787
Abstract

Simple oil formulations are widely used in oral drug delivery and the fate of these systems is governed mainly by the dispersion and digestion process. The current work aimed to study concentration effects of six poorly water-soluble drugs on the in vitro lipolysis rate of medium-chain triglycerides. The results were compared with drug effects on oil viscosity and surface tension. First the different drugs were characterized by molecular modeling and their influence on physical oil properties was assessed. Herein capillary viscosimetry was employed as well as dynamic surface tensiometry. Subsequently, an apparent in vitro lipolysis rate was determined in biorelevant medium using an automated pH stat titrator linked to a thermo-controlled vessel. The different drugs exhibited varying effects on oil viscosity and surface tension. However, all drugs significantly lowered the apparent lipolysis rate of the oil. This effect was very similar among the different compounds with exception of orlistat, which practically blocked lipolysis because of a potent direct inhibition. The other drugs affected lipolysis kinetics most likely by different mechanism(s). In light of the obtained results, a drug effect on oil viscosity or surface tension appeared to play a minor role in reducing the lipolysis rate. The lipolysis kinetics was further not affected by the drug load, which was deemed advantageous from a pharmaceutical viewpoint. Different dose strengths are therefore not assumed to alter lipolysis kinetics, which is beneficial for limiting the variability of in vivo drug release. Further studies of drug solubility kinetics in the evolving digestion phases are, however, needed to finally assess potential effects of dosage strength in simple oil formulations.

摘要

简单的油制剂广泛应用于口服药物传递系统,这些系统的命运主要由分散和消化过程决定。目前的工作旨在研究六种疏水性差的药物对中链甘油三酯体外脂肪分解率的浓度效应。将结果与药物对油粘度和表面张力的影响进行了比较。首先通过分子建模对不同的药物进行了表征,并评估了它们对物理油性质的影响。本文采用了毛细管粘度计和动态表面张力计。随后,使用与控温容器相连的自动 pH -stat 滴定仪在生物相关介质中确定了明显的体外脂肪分解率。不同的药物对油的粘度和表面张力表现出不同的影响。然而,所有的药物都显著降低了油的表观脂肪分解率。除了奥利司他,因为直接抑制作用很强,几乎阻断了脂肪分解,所以这种作用在不同的化合物之间非常相似。其他药物可能通过不同的机制影响脂肪分解动力学。根据获得的结果,药物对油粘度或表面张力的影响在降低脂肪分解率方面似乎作用较小。脂肪分解动力学进一步不受药物负荷的影响,这从药物的角度来看是有利的。因此,不同的剂量强度不被认为会改变脂肪分解动力学,这有利于限制体内药物释放的可变性。然而,还需要进一步研究药物在不断变化的消化阶段中的溶解度动力学,以最终评估简单油制剂中剂量强度的潜在影响。

相似文献

1
Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension.研究考虑油的粘度和表面张力时,药物浓度对中链甘油三酯体外脂肪分解动力学的影响。
Eur J Pharm Sci. 2011 Oct 9;44(3):351-8. doi: 10.1016/j.ejps.2011.08.009. Epub 2011 Aug 25.
2
In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life.脂质药物递送辅料的体外消化动力学及相对脂解半衰期的提出。
Drug Dev Ind Pharm. 2012 Oct;38(10):1262-9. doi: 10.3109/03639045.2011.645834. Epub 2011 Dec 30.
3
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.通过体外动态脂解模型优化口服脂质体药物递送系统的选择,以提高难溶性药物的口服生物利用度。
J Control Release. 2008 Jul 2;129(1):1-10. doi: 10.1016/j.jconrel.2008.03.021. Epub 2008 Apr 1.
4
Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols.中链和长链三酰甘油体外脂解过程中难溶性药物的增溶作用。
Eur J Pharm Sci. 2004 Nov;23(3):287-96. doi: 10.1016/j.ejps.2004.08.003.
5
Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis.链长会影响胰腺脂肪酶的活性以及甘油三酯脂解的程度和pH-时间曲线。
Eur J Pharm Biopharm. 2015 Jun;93:353-62. doi: 10.1016/j.ejpb.2015.04.027. Epub 2015 May 1.
6
Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.通过高粘度羟丙基甲基纤维素实现固体自微乳化制剂中难溶性药物的可控释放。
Eur J Pharm Sci. 2008 Aug 7;34(4-5):274-80. doi: 10.1016/j.ejps.2008.04.010. Epub 2008 May 4.
7
Insulin-loaded W/O/W multiple emulsions: comparison of the performances of systems prepared with medium-chain-triglycerides and fish oil.载胰岛素的水包油包水多重乳液:中链甘油三酯和鱼油制备体系的性能比较
Eur J Pharm Biopharm. 2004 Nov;58(3):477-82. doi: 10.1016/j.ejpb.2004.03.024.
8
A simplified method to screen for in-vivo performance of oral lipid formulations.一种筛选口服脂质制剂体内性能的简化方法。
J Pharm Pharmacol. 2014 May;66(5):615-23. doi: 10.1111/jphp.12182. Epub 2013 Dec 3.
9
Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.基于脂质的制剂可提高难溶性药物茴三硫的口服生物利用度:脂质组成和制剂的影响
Int J Pharm. 2009 Sep 8;379(1):18-24. doi: 10.1016/j.ijpharm.2009.06.001. Epub 2009 Jun 7.
10
Enhancing intestinal drug solubilisation using lipid-based delivery systems.使用基于脂质的递送系统增强肠道药物溶解
Adv Drug Deliv Rev. 2008 Mar 17;60(6):673-91. doi: 10.1016/j.addr.2007.10.014. Epub 2007 Nov 7.

引用本文的文献

1
The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.难溶性药物的沉淀行为,重点在于脂质体制剂的溶出
Pharm Res. 2016 Mar;33(3):548-62. doi: 10.1007/s11095-015-1829-5. Epub 2015 Nov 23.
2
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.为了建立标准化的基于脂质的制剂的体外测试,第 3 部分:了解 I 型、II 型、IIIA 型、IIIB 型和 IV 型基于脂质的制剂在体外消化过程中的过饱和度与沉淀潜力。
Pharm Res. 2013 Dec;30(12):3059-76. doi: 10.1007/s11095-013-1038-z. Epub 2013 May 10.
3
Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.采用在线拉曼光谱和数学建模研究脂基药物传递系统在体外消化过程中药物沉淀动力学。
Pharm Res. 2013 Dec;30(12):3114-30. doi: 10.1007/s11095-013-0999-2. Epub 2013 Feb 28.